REXAHN PHARMACEUTICALS, INC. Collaboration Agreements
5 Contracts & Agreements
- License and Collaboration Agreement dated as of November 6, 2022 by and between Ocuphire Pharma, Inc. and Famy (Filed With SEC on November 7, 2022)
- Amendment No. 2 to Collaboration and License Agreement, dated as of March 10, 2020 between BioSense Global LLC and Rexahn Pharmaceuticals, Inc (Filed With SEC on May 7, 2020)
- Amendment No. 1 to Collaboration and License Agreement (Filed With SEC on August 29, 2019)
- Collaboration and License Agreement, dated as of February 25, 2019, between BioSense Global LLC and Rexahn Pharmaceuticals, Inc (Filed With SEC on August 7, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated August 13, 2018, by and between Merck Sharp & Dohme B.V., and Rexahn Pharmaceuticals, Inc (Filed With SEC on November 2, 2018)
